Literature DB >> 2300208

Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II.

L Rohrer1, M Freeman, T Kodama, M Penman, M Krieger.   

Abstract

The macrophage scavenger receptor, which has been implicated in the pathogenesis of atherosclerosis, has an unusually broad binding specificity. Ligands include modified low-density lipoprotein and some polyanions (for example, poly(I) but not poly(C]. The scavenger receptor type I (ref. 3) has three principal extracellular domains that could participate in ligand binding: two fibrous coiled-coil domains (alpha-helical coiled-coil domain IV and collagen-like domain V), and the 110-amino-acid cysteine-rich C-terminal domain VI. We have cloned complementary DNAs encoding a second scavenger receptor which we have termed type II. This receptor is identical to the type I receptor, except that the cysteine-rich domain is replaced by a six-residue C terminus. Despite this truncation, the type II receptor mediates endocytosis of chemically modified low-density lipoprotein with high affinity and specificity, similar to that of the type I receptor. Therefore one or both of the extracellular fibrous domains are responsible for the unusual ligand-binding specificity of the receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300208     DOI: 10.1038/343570a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Differentiation of binding sites on reconstituted hepatic scavenger receptors using oxidized low-density lipoprotein.

Authors:  E Ottnad; D P Via; J Frübis; H Sinn; E Friedrich; R Ziegler; H A Dresel
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences.

Authors:  K S Moulton; H Wu; J Barnett; S Parthasarathy; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 4.  Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.

Authors:  Sascha N Goonewardena
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

5.  SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Marko Sankala; Silvana Savino; Mariagrazia Pizza; Rino Rappuoli; Karl Tryggvason; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-09-11       Impact factor: 7.349

6.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Authors:  D Praticò; L Iuliano; A Mauriello; L Spagnoli; J A Lawson; J Rokach; J Maclouf; F Violi; G A FitzGerald
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

8.  Understanding molecular interactions between scavenger receptor A and its natural product inhibitors through molecular modeling studies.

Authors:  Piyusha P Pagare; Saheem A Zaidi; Xiaomei Zhang; Xia Li; Xiaofei Yu; Xiang-Yang Wang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2017-08-16       Impact factor: 2.518

9.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.